Showing results (1061-1070 of 1,136) with videos related to

Sort By:
Pageof 114
Blood|June 25, 2013
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responsesGiulia Nizzoli, Jana Krietsch, Anja Weick, et al.
Molecular Neurobiology|March 1, 2018
Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental DisordersAnnalisa Nobili, Paraskevi Krashia, Alberto Cordella, et al.
Journal of Medicinal Chemistry|June 7, 2021
Synthesis and Characterization of Novel Mono- and Bis-Guanyl Hydrazones as Potent and Selective ASIC1 Inhibitors Able to Reduce Brain Ischemic InsultDavide Gornati, Roselia Ciccone, Antonio Vinciguerra, et al.
Oncogenesis|October 19, 2020
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein responseMaria Valeria Giuli, Giulia Diluvio, Eugenia Giuliani, et al.
Molecular Pharmacology|October 16, 2012
Neurounina-1, a novel compound that increases Na+/Ca2+ exchanger activity, effectively protects against stroke damagePasquale Molinaro, Maria Cantile, Ornella Cuomo, et al.
ACS Chemical Neuroscience|May 6, 2015
Pharmacological characterization of the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) as a potent NCX3 inhibitor that worsens anoxic injury in cortical neurons, organotypic hippocampal cultures, and ischemic brainAgnese Secondo, Giuseppe Pignataro, Paolo Ambrosino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2022
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Alessandra Di Filippo, Andrea Botticelli, et al.
Plos One|July 4, 2017
Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged ratsDouglas M Bennion, Jacob D Isenberg, Allison T Harmel, et al.
World Journal of Urology|December 7, 2018
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trialsMatteo Ferro, Giuseppe Di Lorenzo, Ottavio de Cobelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2025
Novel 1,4-benzothiazepin-2-one modulators of NCX3 as a promising strategy for neuroprotection in cerebral ischemiaAntonia Scognamiglio, Angela Corvino, Agata Zięba, et al.
Pageof 114